معرفی
Professor Julie Makani is an Associate Professor at Muhimbili University of Health and Allied Sciences (Department of Haematology and Blood Transfusion) and holds a visiting role as Provost Visiting Professor at Imperial College London’s Faculty of Medicine. She specializes in sickle cell disease (SCD), focusing on genomics, public health interventions, and curative therapies. Her work integrates clinical research with global health advocacy, aiming to improve outcomes in Africa.
Education: MD (Tanzania), specialized in Internal Medicine (UK), and a PhD in clinical epidemiology of SCD (UK). She has held fellowships including the Wellcome Trust Research Fellow and Tutu Leadership Fellow. Her career includes roles at the University of Oxford and leadership in initiatives such as the SickleInAfrica consortium and H3ABioNet.
Research Interests: SCD epidemiology, gene therapy, pharmacogenomics, and public health strategies. She leads large-scale studies like the SickleInAfrica registry and explores barriers to hydroxyurea access and genetic modifiers of disease severity.
Articles: Recent work focuses on SCD’s global burden, gene therapy accessibility, and psychosocial factors influencing treatment adherence. Key themes include improving healthcare systems in low-resource settings and advancing genomic medicine approaches.
- Awards: 2011 Royal Society Africa Award, Fellowships from the Royal College of Physicians and Tanzania Academy of Sciences.
- Grants/Projects: Wellcome Trust funding, SickleInAfrica collaborative research, and initiatives to strengthen African bioinformatics capacity.
Labs/Teams: Leads the Muhimbili Sickle Cell Program, a hub for clinical care and research, and collaborates with global networks like the African Society of Human Genetics.
